Lista de obras - Axel Finckh - Dominio Público Uruguay

2017 EULAR recommendations for a core data set to support observational research and clinical care in rheumatoid arthritis

artículo científico publicado en 2018

A comparison of patient characteristics and outcomes in selected European and U.S. rheumatoid arthritis registries

artículo científico publicado en 2010

A randomized controlled trial of dehydroepiandrosterone in postmenopausal women with fibromyalgia.

artículo científico publicado en 2005

Adalimumab in acute sciatica reduces the long-term need for surgery: a 3-year follow-up of a randomised double-blind placebo-controlled trial

artículo científico publicado en 2011

Adalimumab in severe and acute sciatica: A multicenter, randomized, double-blind, placebo-controlled trial

artículo científico publicado en 2010

Adipokines correlate with pain in lower limb osteoarthritis: different associations in hip and knee

artículo científico publicado en 2014

Anaemia may add information to standardised disease activity assessment to predict radiographic damage in rheumatoid arthritis: a prospective cohort study.

scientific article published on 16 March 2013

Anti-apolipoprotein A-1 IgG predicts major cardiovascular events in patients with rheumatoid arthritis

scholarly article by Nicolas Vuilleumier et al published 6 May 2010 in Arthritis and Rheumatism

Anti-cyclic citrullinated peptide antibodies in the diagnosis of rheumatoid arthritis: bayes clears the haze

artículo científico publicado en 2007

Anti-tumor necrosis factor drug survival in axial spondyloarthritis is independent of the classification criteria.

artículo científico publicado en 2014

Association of spondylarthropathies with lumbar synovial cysts

artículo científico publicado en 2003

Autoimmunity and inflammation are independent of class II transactivator type PIV-dependent class II major histocompatibility complex expression in peripheral tissues during collagen-induced arthritis

artículo científico publicado en 2011

B cell depletion may be more effective than switching to an alternative anti-tumor necrosis factor agent in rheumatoid arthritis patients with inadequate response to anti-tumor necrosis factor agents

artículo científico publicado en 2007

BMI and severity of clinical and radiographic signs of hip osteoarthritis

artículo científico publicado en 2009

Barriers to a trial of atherosclerosis prevention in systemic lupus erythematosus

artículo científico publicado en 2005

Body mass does not impact the clinical response to intravenous abatacept in patients with rheumatoid arthritis. Analysis from the "pan-European registry collaboration for abatacept (PANABA).

artículo científico publicado en 2016

Cardiovascular complications in immune mediated diseases

artículo científico publicado el 13 de marzo de 2013

Cardiovascular risks of cyclooxygenase-2 inhibitors: where we stand now

scientific article published on 01 February 2005

Chronic NSAID use and long-term decline of renal function in a prospective rheumatoid arthritis cohort study.

artículo científico publicado en 2013

Cigarette smoking and radiographic progression in rheumatoid arthritis

artículo científico publicado en 2007

Clinical experience with mycophenolate mofetil in systemic autoimmune conditions refractory to common immunosuppressive therapies

artículo científico publicado en 2009

Comparative effectiveness of biologic antirheumatic therapies in rheumatoid arthritis after failure to respond to a first TNF inhibitor

artículo científico publicado en 2012

Comparative effectiveness of rheumatoid arthritis therapies

artículo científico publicado en 2010

Comparison of drug retention rates and causes of drug discontinuation between anti-tumor necrosis factor agents in rheumatoid arthritis

artículo científico publicado en 2009

Cost-effectiveness of biologics in early rheumatoid arthritis

scientific article published on 01 March 2010

Differential drug retention between anti-TNF agents and alternative biological agents after inadequate response to an anti-TNF agent in rheumatoid arthritis patients

artículo científico publicado en 2012

Disease activity in rheumatoid arthritis patients at initiation of biologic agents and 1 year of treatment: results from the Swiss SCQM registry

artículo científico publicado en 2012

Disease severity in K/BxN serum transfer-induced arthritis is not affected by IL-33 deficiency ⬇️

artículo científico publicado el 16 de enero de 2013

Do new biologics meet the unmet medical need in rheumatoid arthritis? Safety and efficacy of abatacept following B-cell depletion

artículo científico publicado en 2010

Do synovial leptin levels correlate with pain in end stage arthritis?

artículo científico publicado en 2013

EULAR points to consider for the diagnosis and management of rheumatic immune-related adverse events due to cancer immunotherapy with checkpoint inhibitors

scientific article published on 23 April 2020

EULAR points to consider when establishing, analysing and reporting safety data of biologics registers in rheumatology

artículo científico publicado en 2010

EULAR recommendations for terminology and research in individuals at risk of rheumatoid arthritis: report from the Study Group for Risk Factors for Rheumatoid Arthritis

artículo científico publicado en 2012

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update ⬇️

artículo científico publicado en 2017

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update

artículo científico publicado en 2020

Early inflammatory arthritis versus rheumatoid arthritis

artículo científico publicado en 2009

Efficacy of B cell depletion in patients with rheumatoid arthritis refractory to anti-tumour necrosis factor alpha agents: an open-label observational study.

artículo científico publicado en 2006

Elevated Levels of Tumor Necrosis Factor-Alpha in Periradicular Fat Tissue in Patients With Radiculopathy From Herniated Disc

artículo científico publicado en 2008

Evaluation of cardiovascular risk in patients with rheumatoid arthritis: do cardiovascular biomarkers offer added predictive ability over established clinical risk scores?

artículo científico publicado en 2012

Evidence for differential acquired drug resistance to anti-tumour necrosis factor agents in rheumatoid arthritis.

artículo científico publicado en 2005

Evolution of radiographic joint damage in rituximab-treated versus TNF-treated rheumatoid arthritis cases with inadequate response to TNF antagonists

artículo científico publicado en 2012

Immune-mediated experimental arthritis in IL-33 deficient mice

artículo científico publicado en 2014

Impact of the COVID-19 pandemic on the disease course of patients with inflammatory rheumatic diseases: results from the Swiss Clinical Quality Management cohort

scientific article published on 22 September 2020

Indirect comparisons of the efficacy of biological antirheumatic agents in rheumatoid arthritis in patients with an inadequate response to conventional disease-modifying antirheumatic drugs or to an anti-tumour necrosis factor agent: a meta-analysis

artículo científico publicado en 2010

Influence of COVID-19 pandemic on decisions for the management of people with inflammatory rheumatic and musculoskeletal diseases: a survey among EULAR countries

artículo científico publicado en 2020

Influence of anti-infliximab antibodies and residual infliximab concentrations on the occurrence of acquired drug resistance to infliximab in rheumatoid arthritis patients

artículo científico publicado en 2010

Influence of cytokine inhibitors on concentration and activity of MMP-1 and MMP-3 in disc herniation

artículo científico publicado en 2009

Inhibition of interleukin-33 signaling attenuates the severity of experimental arthritis

artículo científico publicado en 2009

Is radiographic progression of late-onset rheumatoid arthritis different from young-onset rheumatoid arthritis? Results from the Swiss prospective observational cohort

artículo científico publicado en 2013

Is the prevention of rheumatoid arthritis possible?

artículo científico publicado en 2020

Joint damage progression in patients with rheumatoid arthritis in clinical remission: do biologics perform better than synthetic antirheumatic drugs?

artículo científico publicado en 2014

Long-term impact of early treatment on radiographic progression in rheumatoid arthritis: A meta-analysis.

artículo científico publicado en 2006

Measuring ACPA in the general population or primary care: is it useful?

scientific article published on 01 February 2020

Menopause and Possible Effect on Association Between Age and Anticyclic Citrullinated Peptide Antibodies in Women At Risk of Rheumatoid Arthritis

artículo científico publicado en 2019

Methotrexate as an alternative therapy for chronic calcium pyrophosphate deposition disease: an exploratory analysis

artículo científico publicado en 2007

Multiple computer-based methods of measuring joint space width can discriminate between treatment arms in the COBRA trial -- Update of an ongoing OMERACT project

artículo científico publicado en 2009

Neurophysiologic evidence for a central sensitization in patients with fibromyalgia ⬇️

artículo científico publicado el 1 de mayo de 2003

Neutral functional realignment orthosis prevents hand pain in patients with subacute stroke: a randomized trial

artículo científico publicado en 2008

Occupational silica and solvent exposures and risk of systemic lupus erythematosus in urban women

artículo científico publicado en 2006

Osteoarthritis: Small studies overestimate the benefit of therapies for OA

scientific article published on 01 November 2010

Pain as an important predictor of psychosocial health in patients with rheumatoid arthritis

artículo científico publicado en 2012

Performance of an automated computer-based scoring method to assess joint space narrowing in rheumatoid arthritis: a longitudinal study

artículo científico publicado en 2006

Persistence of ultrasound synovitis in patients with rheumatoid arthritis fulfilling the DAS28 and/or the new ACR/EULAR RA remission definitions: results of an observational cohort study

artículo científico publicado en 2014

Points to consider for reporting, screening for and preventing selected comorbidities in chronic inflammatory rheumatic diseases in daily practice: a EULAR initiative

artículo científico publicado en 2016

Primary prevention of rheumatoid arthritis: a qualitative study in a high-risk population

artículo científico publicado en 2013

Primer: strengths and weaknesses of meta-analysis.

artículo científico publicado en 2008

Radiographic joint space width in the fingers of patients with rheumatoid arthritis of less than one year's duration

artículo científico publicado en 2006

Response to 'Correspondence on 'Impact of the COVID-19 pandemic on the disease course of patients with inflammatory rheumatic diseases: results from the Swiss Clinical Quality Management cohort' by Ruyssen-Witrand et al

scientific article published on 11 November 2020

Response to: 'Correspondence on '<i>Prevotella copri</i> in individuals at risk for rheumatoid arthritis'' by Sun and Ni

artículo científico publicado en 2020

Risk of invasive melanoma in patients with rheumatoid arthritis treated with biologics: results from a collaborative project of 11 European biologic registers

artículo científico publicado en 2016

Short-term efficacy of intravenous pulse glucocorticoids in acute discogenic sciatica. A randomized controlled trial

artículo científico publicado en 2006

Smoking and spondyloarthritis.

artículo científico publicado en 2012

Spontaneous secretion of interleukin-17 and -22 by human cervical cells in Chlamydia trachomatis infection

artículo científico publicado en 2010

Swiss consensus statement: Recommendations for optimising re-treatment with MabThera (rituximab) in rheumatoid arthritis.

artículo científico publicado en 2010

Symptomatic effects of chondroitin 4 and chondroitin 6 sulfate on hand osteoarthritis: a randomized, double-blind, placebo-controlled clinical trial at a single center

artículo científico publicado en 2011

The EULAR Study Group for Registers and Observational Drug Studies: comparability of the patient case mix in the European biologic disease modifying anti-rheumatic drug registers

artículo científico publicado en 2014

The Role of Nutritional Factors and Intestinal Microbiota in Rheumatoid Arthritis Development

scientific article published on 30 December 2020

The cervical spine in calcium pyrophosphate dihydrate deposition disease. A prevalent case-control study.

artículo científico publicado en 2004

The effect of alcohol on radiographic progression in rheumatoid arthritis

artículo científico publicado en 2010

The effectiveness of anti–tumor necrosis factor therapy in preventing progressive radiographic joint damage in rheumatoid arthritis: A population-based study

scientific article published on 01 January 2006

The effectiveness of leflunomide as a co-therapy of tumour necrosis factor inhibitors in rheumatoid arthritis: a population-based study

artículo científico publicado en 2008

The exercise prescription in rheumatoid arthritis: primum non nocere

artículo científico publicado en 2003

The importance of early treatment for the prognosis of rheumatoid arthritis

artículo científico

The long-term impact of early treatment of rheumatoid arthritis on radiographic progression: a population-based cohort study

scientific article published on 21 January 2011

The new 2010 ACR/EULAR criteria as predictor of clinical and radiographic response in patients with early arthritis

artículo científico publicado en 2014

Tocilizumab in the treatment of rheumatoid arthritis: a cost-effectiveness analysis in the UK.

artículo científico publicado en 2014

Tolerance and effectiveness of anti–tumor necrosis factor α therapies in elderly patients with rheumatoid arthritis: A population-based cohort study

scientific article published on 01 May 2007

Treatment of very early rheumatoid arthritis with symptomatic therapy, disease-modifying antirheumatic drugs, or biologic agents: a cost-effectiveness analysis

artículo científico publicado en 2009

Treatment options in patients with rheumatoid arthritis failing initial TNF inhibitor therapy: a critical review

artículo científico publicado en 2009

Ultrasound evaluation of synovitis in RA: correlation with clinical disease activity and sensitivity to change in an observational cohort study

artículo científico publicado en 2013

Validation of questionnaire-based response criteria of treatment efficacy in the fibromyalgia syndrome

scientific article published on 01 April 1998

Which subgroup of patients with rheumatoid arthritis benefits from switching to rituximab versus alternative anti-tumour necrosis factor (TNF) agents after previous failure of an anti-TNF agent?

artículo científico publicado en 2009

[Diagnostic strategy in presence of diffuse pain]

artículo científico publicado en 2007

[Review of the protective effects of tumor necrosis factor inhibitors in rheumatoid arthritis]

scientific article published on 01 September 2004

[Risk factors for the development of rheumatoid arthritis]

scholarly article by Axel Finckh published 1 March 2014 in Revue médicale suisse

Lista de obras de Axel Finckh

2017 EULAR recommendations for a core data set to support observational research and clinical care in rheumatoid arthritis

A comparison of patient characteristics and outcomes in selected European and U.S. rheumatoid arthritis registries

A randomized controlled trial of dehydroepiandrosterone in postmenopausal women with fibromyalgia.

Adalimumab in acute sciatica reduces the long-term need for surgery: a 3-year follow-up of a randomised double-blind placebo-controlled trial

Adalimumab in severe and acute sciatica: A multicenter, randomized, double-blind, placebo-controlled trial

Adipokines correlate with pain in lower limb osteoarthritis: different associations in hip and knee

Anaemia may add information to standardised disease activity assessment to predict radiographic damage in rheumatoid arthritis: a prospective cohort study.

Anti-apolipoprotein A-1 IgG predicts major cardiovascular events in patients with rheumatoid arthritis

Anti-cyclic citrullinated peptide antibodies in the diagnosis of rheumatoid arthritis: bayes clears the haze

Anti-tumor necrosis factor drug survival in axial spondyloarthritis is independent of the classification criteria.

Association of spondylarthropathies with lumbar synovial cysts

Autoimmunity and inflammation are independent of class II transactivator type PIV-dependent class II major histocompatibility complex expression in peripheral tissues during collagen-induced arthritis

B cell depletion may be more effective than switching to an alternative anti-tumor necrosis factor agent in rheumatoid arthritis patients with inadequate response to anti-tumor necrosis factor agents

BMI and severity of clinical and radiographic signs of hip osteoarthritis

Barriers to a trial of atherosclerosis prevention in systemic lupus erythematosus

Body mass does not impact the clinical response to intravenous abatacept in patients with rheumatoid arthritis. Analysis from the "pan-European registry collaboration for abatacept (PANABA).

Cardiovascular complications in immune mediated diseases

Cardiovascular risks of cyclooxygenase-2 inhibitors: where we stand now

Chronic NSAID use and long-term decline of renal function in a prospective rheumatoid arthritis cohort study.

Cigarette smoking and radiographic progression in rheumatoid arthritis

Clinical experience with mycophenolate mofetil in systemic autoimmune conditions refractory to common immunosuppressive therapies

Comparative effectiveness of biologic antirheumatic therapies in rheumatoid arthritis after failure to respond to a first TNF inhibitor

Comparative effectiveness of rheumatoid arthritis therapies

Comparison of drug retention rates and causes of drug discontinuation between anti-tumor necrosis factor agents in rheumatoid arthritis

Cost-effectiveness of biologics in early rheumatoid arthritis

Differential drug retention between anti-TNF agents and alternative biological agents after inadequate response to an anti-TNF agent in rheumatoid arthritis patients

Disease activity in rheumatoid arthritis patients at initiation of biologic agents and 1 year of treatment: results from the Swiss SCQM registry

Disease severity in K/BxN serum transfer-induced arthritis is not affected by IL-33 deficiency ⬇️

Do new biologics meet the unmet medical need in rheumatoid arthritis? Safety and efficacy of abatacept following B-cell depletion

Do synovial leptin levels correlate with pain in end stage arthritis?

EULAR points to consider for the diagnosis and management of rheumatic immune-related adverse events due to cancer immunotherapy with checkpoint inhibitors

EULAR points to consider when establishing, analysing and reporting safety data of biologics registers in rheumatology

EULAR recommendations for terminology and research in individuals at risk of rheumatoid arthritis: report from the Study Group for Risk Factors for Rheumatoid Arthritis

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update ⬇️

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update

Early inflammatory arthritis versus rheumatoid arthritis

Efficacy of B cell depletion in patients with rheumatoid arthritis refractory to anti-tumour necrosis factor alpha agents: an open-label observational study.

Elevated Levels of Tumor Necrosis Factor-Alpha in Periradicular Fat Tissue in Patients With Radiculopathy From Herniated Disc

Evaluation of cardiovascular risk in patients with rheumatoid arthritis: do cardiovascular biomarkers offer added predictive ability over established clinical risk scores?

Evidence for differential acquired drug resistance to anti-tumour necrosis factor agents in rheumatoid arthritis.

Evolution of radiographic joint damage in rituximab-treated versus TNF-treated rheumatoid arthritis cases with inadequate response to TNF antagonists

Immune-mediated experimental arthritis in IL-33 deficient mice

Impact of the COVID-19 pandemic on the disease course of patients with inflammatory rheumatic diseases: results from the Swiss Clinical Quality Management cohort

Indirect comparisons of the efficacy of biological antirheumatic agents in rheumatoid arthritis in patients with an inadequate response to conventional disease-modifying antirheumatic drugs or to an anti-tumour necrosis factor agent: a meta-analysis

Influence of COVID-19 pandemic on decisions for the management of people with inflammatory rheumatic and musculoskeletal diseases: a survey among EULAR countries

Influence of anti-infliximab antibodies and residual infliximab concentrations on the occurrence of acquired drug resistance to infliximab in rheumatoid arthritis patients

Influence of cytokine inhibitors on concentration and activity of MMP-1 and MMP-3 in disc herniation

Inhibition of interleukin-33 signaling attenuates the severity of experimental arthritis

Is radiographic progression of late-onset rheumatoid arthritis different from young-onset rheumatoid arthritis? Results from the Swiss prospective observational cohort

Is the prevention of rheumatoid arthritis possible?

Joint damage progression in patients with rheumatoid arthritis in clinical remission: do biologics perform better than synthetic antirheumatic drugs?

Long-term impact of early treatment on radiographic progression in rheumatoid arthritis: A meta-analysis.

Measuring ACPA in the general population or primary care: is it useful?

Menopause and Possible Effect on Association Between Age and Anticyclic Citrullinated Peptide Antibodies in Women At Risk of Rheumatoid Arthritis

Methotrexate as an alternative therapy for chronic calcium pyrophosphate deposition disease: an exploratory analysis

Multiple computer-based methods of measuring joint space width can discriminate between treatment arms in the COBRA trial -- Update of an ongoing OMERACT project

Neurophysiologic evidence for a central sensitization in patients with fibromyalgia ⬇️

Neutral functional realignment orthosis prevents hand pain in patients with subacute stroke: a randomized trial

Occupational silica and solvent exposures and risk of systemic lupus erythematosus in urban women

Osteoarthritis: Small studies overestimate the benefit of therapies for OA

Pain as an important predictor of psychosocial health in patients with rheumatoid arthritis

Performance of an automated computer-based scoring method to assess joint space narrowing in rheumatoid arthritis: a longitudinal study

Persistence of ultrasound synovitis in patients with rheumatoid arthritis fulfilling the DAS28 and/or the new ACR/EULAR RA remission definitions: results of an observational cohort study

Points to consider for reporting, screening for and preventing selected comorbidities in chronic inflammatory rheumatic diseases in daily practice: a EULAR initiative

Primary prevention of rheumatoid arthritis: a qualitative study in a high-risk population

Primer: strengths and weaknesses of meta-analysis.

Radiographic joint space width in the fingers of patients with rheumatoid arthritis of less than one year's duration

Response to 'Correspondence on 'Impact of the COVID-19 pandemic on the disease course of patients with inflammatory rheumatic diseases: results from the Swiss Clinical Quality Management cohort' by Ruyssen-Witrand et al

Response to: 'Correspondence on '<i>Prevotella copri</i> in individuals at risk for rheumatoid arthritis'' by Sun and Ni

Risk of invasive melanoma in patients with rheumatoid arthritis treated with biologics: results from a collaborative project of 11 European biologic registers

Short-term efficacy of intravenous pulse glucocorticoids in acute discogenic sciatica. A randomized controlled trial

Smoking and spondyloarthritis.

Spontaneous secretion of interleukin-17 and -22 by human cervical cells in Chlamydia trachomatis infection

Swiss consensus statement: Recommendations for optimising re-treatment with MabThera (rituximab) in rheumatoid arthritis.

Symptomatic effects of chondroitin 4 and chondroitin 6 sulfate on hand osteoarthritis: a randomized, double-blind, placebo-controlled clinical trial at a single center

The EULAR Study Group for Registers and Observational Drug Studies: comparability of the patient case mix in the European biologic disease modifying anti-rheumatic drug registers

The Role of Nutritional Factors and Intestinal Microbiota in Rheumatoid Arthritis Development

The cervical spine in calcium pyrophosphate dihydrate deposition disease. A prevalent case-control study.

The effect of alcohol on radiographic progression in rheumatoid arthritis